Healthcare -
Biotechnology - NASDAQ - US
$ 2.08
8.9 %
$ 75.1 M
Market Cap
-0.47
P/E
INO - CAPITAL EXPENDITURES
Capital Expenditures INO - Inovio Pharmaceuticals, Inc.
-321 K
LAST VALUE
48.94%
2 YEAR CAGR
31.22%
5 YEAR CAGR
-6.13%
10 YEAR CAGR